Stronger Sell Today PETX ranks #4722 as SELL CANDIDATE #4722 Weaker Sell

Aratana Therapeutics stock forecast

PETX stock forecast

Friday June 14, 2019 Change -1.85% Price $4.78
Chart period: 2019-03-15 - 2019-06-14
VOLUME
Sell
TREND
Buy
MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Social Sentiment for PETX

Today's data is from 1 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
100%
0%
Weighted Sentiment 0.00

Will PETX stock price go up or down on Mon, 17 Jun 2019?

Predict

Aratana Therapeutics Forecast and Stock Analysis

Technical PETX stock analysis for Friday June 14, 2019.

Sell candidate since 2019-06-14


Aratana Therapeutics fell by -1.85% in the last day ( Friday, 14th Jun 2019 ) from $4.87 to $4.78 and has now fallen 3 days in a row. During day the stock fluctuated 2.20% from a day low at $4.77 to a day high of $4.88. The price has fallen in 5 of the last 10 days , but is still up by 3.24% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -117 173 shares and in total 231 479 shares bought and sold for approximately $1.11 million.

Quick summary:

  • 30 day high of the PETX stock price was $4.95 and low was $4.59.
  • 90 day high was $5.04 and low was $3.35.
  • 52 week high for the Aratana Therapeutics - $7.16 and low - $3.30.

Trend

Aratana Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 38.84% during the next 3 months and, with 90% probability hold a price between $6.00 and $7.83 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Aratana Therapeutics holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $4.84 and $4.78. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday June 12, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

A sell signal from a double top formation was found on Wednesday June 12, 2019 and based on theory for this formation the price should fall by -0.41% to $4.47 within 17 trading days since signal was issued (Monday July 08, 2019).

Relative Strength Index (RSI)

RSI14 is 51 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Aratana Therapeutics finds support from accumulated volume at $4.76.

Support: $4.76 Price: $4.78 Resistance: $4.79

Risk

In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

2.16 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

The Aratana Therapeutics stock holds several negative signals and despite the positive trend we believe Aratana Therapeutics will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.

Sell Candidate Downgraded
Stronger Sell Today PETX ranks #4722 as SELL CANDIDATE #4722 Weaker Sell

Will PETX stock price go up or down on Mon, 17 Jun 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank